← The Wire
IBRXNasdaq
ImmunityBio, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1326110
Develops and commercializes therapies and vaccines to activate the immune system against cancers and infectious diseases
$7.44B
Market cap
$8.77
Last close
+0.7%
1D
+21.5%
5D
15.8M
Volume
Price · last 39 sessions+18.0%
May 4L $6.72 · H $8.77Jun 29
195
Total filings
Jun 10, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 10, 20268-KMaterial Agreement · Reg FD DisclosureMay 18, 202610-Q10-QMay 7, 20268-KResults of OperationsMay 7, 2026DEFA14ADEFA14AApr 30, 2026DEF 14ADEF 14AApr 30, 20268-KResults of OperationsApr 9, 20268-KReg FD DisclosureApr 6, 20268-KMaterial Agreement · New Debt / ObligationMar 31, 2026SC 13D/ASC 13D/AFeb 25, 202610-K10-KFeb 23, 20268-KResults of OperationsFeb 23, 20268-KCompany UpdateFeb 18, 20268-KMaterial AgreementJan 26, 20268-KResults of OperationsJan 15, 20268-KCompany UpdateJan 14, 20268-KMaterial Agreement · Company UpdateDec 29, 2025424B5424B5Dec 29, 20258-KExecutive ChangeDec 15, 20258-KCompany UpdateDec 12, 202510-Q10-QNov 5, 20258-KResults of OperationsNov 5, 20258-KCompany UpdateAug 8, 202510-Q10-QAug 5, 20258-KResults of OperationsAug 5, 2025424B5424B5Jul 28, 20258-KMaterial Agreement · Results of OperationsJul 25, 20258-KExecutive Change · Shareholder VoteJun 20, 202510-Q10-QMay 12, 20258-KResults of OperationsMay 12, 20258-KCompany UpdateMay 5, 2025DEFA14ADEFA14AApr 30, 2025DEF 14ADEF 14AApr 30, 20258-KResults of OperationsApr 15, 2025424B5424B5Apr 8, 20258-KMaterial Agreement · Reg FD DisclosureApr 8, 20258-KAuditor ChangeMar 19, 202510-K10-KMar 3, 20258-KResults of OperationsMar 3, 20258-KExecutive ChangeFeb 13, 20258-KExecutive ChangeFeb 7, 2025424B5424B5Dec 12, 20248-KMaterial Agreement · Company UpdateDec 11, 20248-KCompany UpdateDec 10, 2024424B5424B5Dec 10, 20248-KCompany UpdateNov 19, 202410-Q10-QNov 12, 20248-KResults of OperationsNov 12, 202410-Q10-QAug 12, 20248-KMaterial AgreementJul 18, 20248-KShareholder VoteJun 12, 202410-Q10-QMay 9, 2024DEFA14ADEFA14AApr 29, 2024DEF 14ADEF 14AApr 29, 20248-KReg FD Disclosure · Company UpdateApr 23, 202410-K10-KMar 19, 20248-KExecutive Change · Code of EthicsFeb 26, 20248-KMaterial Agreement · New Debt / ObligationJan 2, 202410-Q10-QNov 9, 20238-KMaterial Agreement · New Debt / ObligationSep 11, 20238-KCompany UpdateSep 1, 20238-KCompany UpdateAug 15, 202310-Q10-QAug 8, 2023424B5424B5Jul 25, 2023424B5424B5Jul 24, 20238-KMaterial AgreementJul 21, 20238-KCompany UpdateJul 20, 20238-KMaterial Agreement · New Debt / ObligationJun 14, 202310-Q10-QMay 11, 20238-KCompany UpdateMay 11, 2023DEFA14ADEFA14AApr 28, 2023DEF 14ADEF 14AApr 28, 20238-KMaterial Agreement · New Debt / ObligationMar 31, 20238-KCompany UpdateMar 20, 202310-K10-KMar 1, 2023424B5424B5Feb 16, 20238-KMaterial AgreementFeb 15, 20238-KResults of OperationsFeb 14, 20238-KCompany UpdateFeb 13, 20238-KMaterial Agreement · Results of OperationsDec 12, 2022
Insider Activity
In the 90 days to Feb 24, 2026: 2 sold $4.5M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 24, 2026 | Simon Barry J.Director | Sell | 75,000 | $12.01 | $901K |
| Feb 23, 2026 | Simon Barry J.Director | Sell | 165,000 | $10.25 | $1.7M |
| Feb 23, 2026 | Selecky ChristobelDirector | Sell | 25,000 | $10.00 | $250K |
| Feb 20, 2026 | Simon Barry J.Director | Sell | 10,000 | $9.25 | $93K |
| Jan 20, 2026 | Simon Barry J.Director | Sell | 75,000 | $7.88 | $591K |
| Jan 20, 2026 | Simon Barry J.Director | Sell | 76,967 | $6.54 | $503K |
| Jan 20, 2026 | Selecky ChristobelDirector | Sell | 25,000 | $7.51 | $188K |
| Jan 16, 2026 | Selecky ChristobelDirector | Sell | 50,000 | $5.00 | $250K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
In the News
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance